Karunatilake Chulani 4
4 · Werewolf Therapeutics, Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Karunatilake Chulani
Chief Technology Officer
Transactions
- Award
Stock Option (right to buy)
2022-06-01+136,000→ 136,000 totalExercise: $3.43Exp: 2032-05-31→ Common Stock (136,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 1, 2022 with a Vesting Commencement Date of June 1, 2022. The shares underlying the option vest over three years, with the shares vesting in equal monthly installments through June 1, 2025.